Steven Gelone

Steven Gelone

No open positions remaining
58 year
Health Technology
Consumer Services

Profile

Steven P.
Gelone
is the founder of Hula Therapeutics, Inc. Former jobs include Director-Clinical Pharmacology at GSK Plc from 2000 to 2002, Director-Medical Affairs at Vicuron Pharmaceuticals LLC from 2002 to 2003, Vice President-Clinical & Preclinical Development at Shire ViroPharma, Inc. from 2005 to 2014, Chief Development Officer at Nabriva Therapeutics GmbH from 2014 to 2017, President, Chief Operating Officer & Director at Nabriva Therapeutics Plc from 2021 to 2023, and Head-Clinical Research & Development at Spark Therapeutics, Inc. Education includes undergraduate and doctorate degrees from Temple University (Pennsylvania).

Steven Gelone active positions

CompaniesPositionStart

Former positions of Steven Gelone

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer 29/06/2017
Corporate Officer/Principal 31/12/2013
Chief Tech/Sci/R&D Officer 31/12/2002
GSK PLC Chief Tech/Sci/R&D Officer 31/12/2001
SPARK THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer -
See the detail of Steven Gelone's experience

Training of Steven Gelone

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

72

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology